These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 33581735)
1. Sodium-glucose cotransporter-2-induced euglycemic diabetic ketoacidosis unmasks latent autoimmune diabetes in a patient misdiagnosed with type 2 diabetes mellitus: a case report. Vadasz B; Arazi M; Shukha Y; Koren O; Taher R J Med Case Rep; 2021 Feb; 15(1):62. PubMed ID: 33581735 [TBL] [Abstract][Full Text] [Related]
2. Prevalence and Clinical Characteristics of Adults Presenting With Sodium-Glucose Cotransporter-2 Inhibitor-Associated Diabetic Ketoacidosis at a Canadian Academic Tertiary Care Hospital. Clark A; Mohammed AS; Raut A; Moore S; Houlden R; Awad S Can J Diabetes; 2021 Apr; 45(3):214-219. PubMed ID: 33046401 [TBL] [Abstract][Full Text] [Related]
3. Sodium-glucose cotransporter 2 inhibitor-induced euglycemic diabetic ketoacidosis in a patient with coronavirus disease 2019: a case report. Yii ESS; Azli AW; Sitaram PN J Med Case Rep; 2022 Jan; 16(1):17. PubMed ID: 34983625 [TBL] [Abstract][Full Text] [Related]
4. Euglycemic Diabetic Ketoacidosis Associated With SGLT2 Inhibitor Therapy: A Case Report. Klinkner G; Steingraber-Pharr M AACN Adv Crit Care; 2023 Mar; 34(1):27-32. PubMed ID: 36877649 [TBL] [Abstract][Full Text] [Related]
5. [Diabetic euglycemic ketosis or ketoacidosis in individuals with type 2 diabetes treated by SGLT2 inhibitors: A series of Belgian clinical cases]. Menghoum N; Oriot P; Hermans MP; Mariage JL Rev Med Interne; 2020 Apr; 41(4):226-231. PubMed ID: 31866073 [TBL] [Abstract][Full Text] [Related]
6. Euglycemic Diabetic Ketoacidosis Associated With Sodium-Glucose Cotransporter Type 2 Inhibitors in Patients With Type 2 Diabetes Mellitus Receiving Oral Therapy. Dull RB; Spangler ML; Knezevich EL; Lau BM J Pharm Pract; 2019 Apr; 32(2):240-243. PubMed ID: 29241389 [TBL] [Abstract][Full Text] [Related]
7. Intraoperative Diagnosis of Sodium-Glucose Cotransporter 2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis: A Case Report. Seger CD; Xing H; Wang L; Shin JS A A Pract; 2021 Jan; 15(1):e01380. PubMed ID: 33512907 [TBL] [Abstract][Full Text] [Related]
8. SGLT2 Inhibitors: A Systematic Review of Diabetic Ketoacidosis and Related Risk Factors in the Primary Literature. Burke KR; Schumacher CA; Harpe SE Pharmacotherapy; 2017 Feb; 37(2):187-194. PubMed ID: 27931088 [TBL] [Abstract][Full Text] [Related]
9. Euglycemic Ketoacidosis With Sodium-Glucose Cotransporter-2 Inhibitor. Koch RA; Clark RF Am J Ther; 2018; 25(5):e590-e591. PubMed ID: 28452848 [No Abstract] [Full Text] [Related]
10. Real life evaluation of sodium-glucose cotransporter 2 inhibition in type 1 diabetes and the risk of diabetic ketoacidosis. Stougaard EB; Kristensen PL; Kielgast U; Andersen HU; Hamid Y; Gæde PH; Søndergaard E; Dørflinger GH; Fjeldborg KK; Hansen KW; Thomsen HH; Al-Imar TMJ; Røder M; Sridhar VS; Cherney D; Rossing P; Persson F Diab Vasc Dis Res; 2022; 19(5):14791641221130043. PubMed ID: 36262089 [TBL] [Abstract][Full Text] [Related]
11. Euglycemic diabetic ketoacidosis induced by sodium-glucose cotransporter 2 inhibitor in the setting of prolonged fasting: a case report. Alkatheeri A; Alseddeeqi E J Med Case Rep; 2022 Mar; 16(1):138. PubMed ID: 35346357 [TBL] [Abstract][Full Text] [Related]
12. Euglycemic diabetic ketoacidosis associated with the use of a sodium-glucose cotransporter-2 inhibitor. Zhang L; Tamilia M CMAJ; 2018 Jun; 190(25):E766-E768. PubMed ID: 29941433 [No Abstract] [Full Text] [Related]
13. Early detection of euglycemic ketoacidosis during thoracic surgery associated with empagliflozin in a patient with type 2 diabetes: A case report. Kitahara C; Morita S; Kishimoto S; Matsuno S; Uraki S; Takeshima K; Furukawa Y; Inaba H; Iwakura H; Ariyasu H; Furuta H; Nishi M; Akamizu T J Diabetes Investig; 2021 Apr; 12(4):664-667. PubMed ID: 32686282 [TBL] [Abstract][Full Text] [Related]
14. Life-Threatening Complications Related to Delayed Diagnosis of Euglycemic Diabetic Ketoacidosis Associated with Sodium-Glucose Cotransporter-2 Inhibitors: A Report of 2 Cases. Goto S; Ishikawa JY; Idei M; Iwabuchi M; Namekawa M; Nomura T Am J Case Rep; 2021 Mar; 22():e929773. PubMed ID: 33723205 [TBL] [Abstract][Full Text] [Related]
15. Diabetic Ketoacidosis in Patients with Type 2 Diabetes on Sodium-Glucose Cotransporter-2 Inhibitors - A Case Series. Sharma PV; Jobanputra YB; Lewin K; Bagatell S; Lichtstein DM Rev Recent Clin Trials; 2018; 13(2):156-160. PubMed ID: 29542418 [TBL] [Abstract][Full Text] [Related]
16. Euglycemic diabetic ketoacidosis associated with sodium-glucose cotransporter type 2 inhibitors. Isern de Val Í; Mercado Castillo H; Díaz Melé MDC Med Clin (Barc); 2024 Jul; 163(2):101-102. PubMed ID: 38677916 [No Abstract] [Full Text] [Related]
17. Euglycemic diabetic ketoacidosis in a patient on sodium-glucose cotransporter 2 inhibitors. Hammond DB; Ingram CC JAAPA; 2023 Sep; 36(9):1-3. PubMed ID: 37668485 [TBL] [Abstract][Full Text] [Related]
18. Sodium-glucose cotransporter-2 inhibitor-induced euglycemic diabetic ketoacidosis: A case report. Han J; Xie S; Jiao H J Clin Pharm Ther; 2022 Sep; 47(9):1482-1485. PubMed ID: 35949163 [No Abstract] [Full Text] [Related]